Andrew Badley, MD, is the Chair of the Mayo COVID-19 Research Taskforce. Dr. Badley is a well-known physician and researcher who focuses on virus-host interactions, particularly on how viral proteins modify the host-immune response and on cell survival. Dr. Badley has spent 19 years with the Mayo Clinic in various roles. Currently, Dr. Badley is a Professor of Infectious Disease, serves as the Chair of the Mayo Clinic COVID-19 Research Taskforce, and is Professor and Chair of the Department of Molecular Medicine. Dr. Badley began his career at the University of Ottawa, where he served as an Associate Professor as well as Infectious Disease Physician. Dr. Badley received his bachelors and medical degrees from Dalhousie University. After Dalhousie, Dr. Badley completed his residency in internal medicine and his fellowship in infectious disease at Mayo School of Graduate Medical Education.
Michael Diamond, MD, PhD Washington University of Medicine
Dr. Michael Diamond is the Herbert S. Gasser Professor of Medicine and a Professor of Molecular Microbiology and of Pathology and Immunology at the Washington University School of Medicine. He is also an Associate Director for the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. He is recognized internationally for his research involving Zika, West Nile, chikungunya, SARS-CoV-2 and related emerging RNA viruses.
Jeffrey Henderson, MD, PhD Washington University of Medicine
Dr. Jeffrey Henderson is an Associate Professor of Medicine and Molecular Microbiology at Washington University at St. Louis. Dr. Henderson’s research uses interdisciplinary approaches to better understand infection pathogenesis in patients and to devise improved therapeutic and preventive strategies. Dr. Henderson is also a member of the National COVID-19 Convalescent Plasma Project (CCPP19), a group of physicians and scientists from 57 institutions in 46 states who have self-organized for the purpose of investigating the potential use of convalescent plasma in the current COVID-19 pandemic.
Shmuel Shoham, MD, PhD Johns Hopkins University School of Medicine
Dr. Shmuel Shoham is an Associate Professor at Johns Hopkins University School of Medicine. He has over 20 years of experience in the management of patients with invasive infections and is the author or co-author of over 100 original articles, book chapters and topic reviews. He is a nationally-recognized expert in infectious diseases of immunocompromised patients and his research explores diagnosis, prevention and treatment of infections in such patients. Dr. Shoham is also a member of the National COVID-19 Convalescent Plasma Project (CCPP19), a group of physicians and scientists from 57 institutions in 46 states who have self-organized for the purpose of investigating the potential use of convalescent plasma in the current COVID-19 pandemic.
Susan Weiss, PhD University of Pennsylvania
Dr. Susan Weiss is a Professor and Vice Chair of the Department of Microbiology at the Perelman School of Medicine at the University of Pennsylvania and a Co-Director at the Penn Center for Research on Coronaviruses and Other Emerging Pathogens. Her forty years of coronavirus research has encompassed a number of emerging pathogens including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2 as well as the human cold viruses OC43 and 229E and the model coronavirus murine hepatitis virus.